This is a working overview of incretin, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-07-06. Anything still debated is marked as such rather than presented as settled.
Identity and purity are established with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry for confirmation of the expected mass. Peptide mapping after enzymatic digestion verifies the primary sequence and detects substitutions. Size-exclusion chromatography quantifies aggregates and fragments, which are the impurities most often tracked for peptides of this size. Residual solvents, counterions, and water content fall under separate tests described in pharmacopeial chapters. Circular dichroism or nuclear magnetic resonance may be used in research settings to probe secondary structure, though such methods are less common in routine release testing.
Peptide active ingredients of this type are typically supplied as lyophilized powder because the dry form resists hydrolysis during transport. The material is hygroscopic, so vials are usually equilibrated to room temperature before opening to avoid condensation on the solid. Repeated freeze-thaw cycles can promote aggregation and are generally avoided by aliquoting stock into single-use portions. Personnel handling the powder work in controlled environments to limit inhalation of fine particles. Written procedures usually specify these steps rather than leaving them to individual judgment.
The peptide activates two G protein-coupled receptors, GIPR and GLP-1R. Binding triggers adenylyl cyclase activity and raises intracellular cyclic AMP in pancreatic beta cells, which potentiates insulin release when glucose is elevated. Signaling in the central nervous system is associated with reduced appetite and lower energy intake, while effects on gastric emptying and glucagon secretion are also reported. Because activity at both receptors is retained, the pharmacological profile is often described as incretin-based rather than selective for a single receptor.
After subcutaneous injection, absorption is gradual, and peak plasma levels are generally reached within one to three days. Albumin binding extends the apparent half-life to roughly five days, which supports a weekly administration schedule. Metabolism proceeds mainly through proteolytic cleavage of the peptide backbone and beta-oxidation of the fatty acid chain, rather than through cytochrome P450 pathways. Eliminated fragments are largely recycled through general protein turnover, and excretion of intact drug in urine is minimal. These properties distinguish the molecule from short-acting incretin mimetics.
Tirzepatide is a synthetic peptide of 39 amino acids engineered from the native glucose-dependent insulinotropic polypeptide sequence. Its structure incorporates several non-natural residues and a C-terminal segment derived from glucagon-like peptide-1, together with a C20 fatty diacid moiety attached through a linker. The lipophilic side chain promotes binding to serum albumin, which slows renal clearance after administration. The compound is classified as a dual incretin receptor agonist and is supplied as a lyophilized powder for reconstitution or as a preformulated solution, depending on the presentation.
| Property | Value | Notes |
|---|---|---|
| Typical supplied form | Lyophilized powder | Hygroscopic, seal promptly after opening |
| Long-term storage temperature | At or below minus 20 C | Protect from repeated freeze-thaw |
| Working solution stability | Hours when refrigerated | Use within the same working day |
| Primary purity method | Reversed-phase HPLC | Often paired with mass spectrometry |
| Aggregate measurement | Size-exclusion chromatography | Reports high-molecular-weight species |
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
Common degradation routes include hydrolysis of labile amide bonds, deamidation of asparagine and glutamine residues, oxidation of methionine and tryptophan, and non-covalent aggregation. Aggregates can form during freeze-thaw cycling, at elevated pH, or when peptide concentration is high. Each route produces characteristic chromatographic or mass shifts that are tracked during stability studies. Whether a given minor impurity alters biological activity is often an open question, and specification limits are typically set on identity and purity rather than on functional data for trace species.
Lyophilized material is generally held at -20 degrees Celsius or lower, desiccated and protected from light, where it remains stable for extended periods. Reconstituted or ready-to-use solution is usually kept at 2 to 8 degrees Celsius with minimal agitation. Repeated freeze-thaw cycles should be avoided because they promote aggregation and reduce the soluble monomer fraction. Shipment of frozen solid commonly uses dry ice, while refrigerated liquid moves with validated cold packs. Stability beyond documented periods is not established.
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, with mass confirmation by electrospray ionisation mass spectrometry. Peptide mapping after enzymatic digestion verifies the primary sequence. Size-exclusion chromatography quantifies aggregates, while circular dichroism provides a secondary-structure fingerprint. Bioanalytical quantification in plasma uses immunoassay or LC-MS/MS. Reported purity for research-grade lots is commonly 95 percent or higher, and residual water content is checked by Karl Fischer titration.
As a peptide, tirzepatide is handled as a lyophilised solid in research settings and as a preserved solution in finished products. Aqueous solubility is pH dependent and reaches a minimum near the isoelectric point, which lies close to pH 5.4. Stock solutions are typically prepared in neutral or slightly basic buffer to limit precipitation. The solid is hygroscopic and should be equilibrated to room temperature before opening so that condensation does not form on the powder surface.
=== Pregnancy and newborns === Antidepressants, including SSRIs, can cross the placenta and have the potential to affect the fetus and newborn, including an increased chance of miscarriage, presenting a dilemma for pregnant women to decide whether to continue to take antidepressants at all, or if they do, considering if tapering and discontinuing during pregnancy could have a protective effect for the newborn. Neonatal withdrawal syndrome was first noticed in 1973 in newborns of mothers taking antidepressants; symptoms in the infant include irritability, rapid breathing, hypothermia, and blood sugar problems. The symptoms usually develop from birth to days after delivery and usually resolve within days or weeks of delivery.
It is said by the tradition, to take away the sins of the devotees when they enter a temple and to ward off evil in general. It is therefore often found in a strategic position on the gopuram or temple gateway, or near the entrance of the sanctum sanctorum.
=== Grenades === No. 36M HE Hand Grenade – In use until the 1970s No. 75 HE Hand Grenade No. 82 HE Hand Grenade No. 94 Anti-Tank Grenade - for use with the Lee-Enfield and then the L1A1. L2A1/A2 HE Hand Grenade – mid-1960s replacement for the Mills bomb. No. 80 Mk 1 White Phosphorus Smoke Hand Grenade No. 83 Mk 1-Mk 3 Coloured/Signal Smoke Hand Grenade series L35-L38 Signal Smoke Hand Grenade series L52-L55 Signal Smoke Hand Grenade series L64-L67 Signal Smoke Hand Grenade series
For services to Urban Regeneration. William James Ferguson, , lately Vice Chairman, Scottish Agricultural College. For services to Agriculture and to Education. Thelma Fisher, Director, National Family Mediation. For services to the community. David Fleming. For services to Museums. Douglas Munro Fleming, General Medical Practitioner, Birmingham. For services to Medicine. George Malcolm Fordy, Chairman and Chief Executive, FT Construction Group. For services to the Building Industry. Michael Hartley Foulds, Member, Association of Chartered Certified Accountants. For services to Accountancy. Major Roy Sutherland Fox. For services to the Soldiers', Sailors' and Airmen's Families Association in Suffolk. Stephen Giles Frankiss, Grade 6, Department of Transport. Jacqueline Dorothy Fuller, Officer in Charge, Board of Inland Revenue. Robert Alan Gailey. For services to Museums and Galleries. William Alistair Galston, lately Chief Inspector, Gaming Board of Great Britain. John Frederick Gibson, Secretary Scientific, Royal Society of Chemistry. For services to Chemistry. Thelma Joyce Gillen, Grade 7, Ministry of Defence. Michael John Goodman, Senior Group Leader, Pulse Power Research, AWE Aldermaston. For services to the Defence Industry. Gerard Graham. For services to the community in Tyne and Wear. William Grant, . For services to Environmental Protection and to the Arts. Frederick Howard Green, Education Adviser, National Association of Independent and non-Maintained Schools. For services to Special Needs Education.
Sources: en.wikipedia.org
=== ATP recycling === The total quantity of ATP in the human body is about 0.1 mol/L. The majority of ATP is recycled from ADP by the aforementioned processes. Thus, at any given time, the total amount of ATP + ADP remains fairly constant. The energy used by human cells in an adult requires the hydrolysis of 100 to 150 mol/L of ATP daily, which means a human will typically use their body weight worth of ATP over the course of the day. Each equivalent of ATP is recycled 1000–1500 times during a single day (150 / 0.1 = 1500), at approximately 9×1020 molecules/s.
1989–1991 – 1.3 L (1,323 cc) B3, 1 barrel, 8-valve, 76 PS (56 kW) / 101 N⋅m (74 lb⋅ft) 1991–1994 – 1.3 L (1,323 cc) B3, EGI-S, 8-valve, 79 PS (58 kW) / 103 N⋅m (76 lb⋅ft) 1989–1991 – 1.5 L (1,498 cc) B5-M, carburetor, 16-valve, 91 PS (67 kW) / 122 N⋅m (90 lb⋅ft) 1990–1994 – 1.5 L (1,498 cc) B5-MI, EGI-S, 16-valve 94 PS (69 kW) / 123 N⋅m (91 lb⋅ft) 1989–1991 – 1.5 L (1,498 cc) B5-DE, EFi, 16-valve DOHC, 110 PS (81 kW) / 127 N⋅m (94 lb⋅ft) 1991–1994 – 1.5 L (1,498 cc) B5-DE, EFi, 16-valve DOHC, 115–120 PS (85–88 kW) / 132 N⋅m (97 lb⋅ft) (lower power for AT cars) 1989–1991 – 1.6 L (1,597 cc) B6, 1 barrel, 8-valve, 85 hp (63 kW; 86 PS) / 92 lb⋅ft (125 N⋅m) 1989–1994 – 1.6 L (1,597 cc) B6, carburetor, 16-valve, SOHC, 103 hp (77 kW; 104 PS) / 108 lb⋅ft (146 N⋅m) 1989–1994 – 1.8 L (1,839 cc) BP, FI, 16-valve DOHC, 140 hp (104 kW; 142 PS) / 118 lb⋅ft (160 N⋅m) 1989–1994 – 1.8 L (1,839 cc) BPT, FI, 16-valve DOHC, turbo, 180 PS (132 kW) / 237 N⋅m (175 lb⋅ft) (Familia GT-X) 1991–1994 – 1.8 L (1,839 cc) B8, FI, 16-valve SOHC, 103 hp (77 kW) 1992–1993 – 1.8 L (1,839 cc) BPD, FI, 16-valve DOHC, turbo, 210 PS (154 kW) / 255 N⋅m (188 lb⋅ft) (Familia GT-R & GT-Ae) 1989–1994 – 1.7 L (1,720 cc) PN, Diesel, 8-valve, 57 PS (42 kW) / 112 N⋅m (83 lb⋅ft) (European specs)
== Y == Ada Yonath (1939–2026). Israeli crystallographer at the Weizmann Institute of Science, best known for her pioneering work on the structure of the ribosome. Nobel Prize in Chemistry (2009). Member Natl. Acad. Sci. USA. Frank Young FRS (1908–1988). British biochemist at Cambridge University, where he was Sir William Dunn Professor for many years. William John Young (1878–1942). British biochemist at the University of Melbourne who worked on fermenting enzymes in yeast extract, and discovered “Harden–Young ester” (fructose 1,6-bisphosphate).
=== KLOC === A computer programming expression, the K-LOC or KLOC, pronounced kay-lok, standing for "kilo-lines of code", i.e., thousand lines of code. The unit was used, especially by IBM managers, to express the amount of work required to develop a piece of software. Given that estimates of 20 lines of functional code per day per programmer were often used, it is apparent that 1 K-LOC could take one programmer as long as 50 working days, or 10 working weeks. This measure is no longer in widespread use because different computer languages require different numbers of lines to achieve the same result (occasionally the measure "assembly equivalent lines of code" is used, with appropriate conversion factors from the language actually used to assembly language). Error rates in programming are also measured in "Errors per K-LOC", which is called the defect density. NASA's SATC is one of the few organizations to claim zero defects in a large (>500K-LOC) project, for the space shuttle software. An alternative measurement was defined by Pegasus Mail author David Harris: the "WaP" is equivalent to 71,500 lines of program code, because that number of lines is the length of one edition of Leo Tolstoy's War and Peace.
The bound sequences are eluted and amplified by PCR to prepare for subsequent rounds of selection in which the stringency of the elution conditions can be increased to identify the tightest-binding sequences. A caution to consider in this method is that the selection of extremely high, sub-nanomolar binding affinity entities may not in fact improve specificity for the target molecule. Off-target binding to related molecules could have significant clinical effects. SELEX has been used to develop a number of aptamers that bind targets interesting for both clinical and research purposes. Nucleotides with chemically modified sugars and bases have been incorporated into SELEX reactions to increase the chemical diversity at each base, expanding the possibilities for specific and sensitive binding, or increasing stability in serum or in vivo.
Sources: en.wikipedia.org
Moore supports hiring more probation and parole officers, pursuing police misconduct allegations, and increasing resources for law enforcement agencies. During his 2022 gubernatorial campaign, he unveiled a public safety plan that includes improving offender services, improving police diversity, and supporting and funding community-based policing and violence intervention programs. He also said that he "believes in policing with maximum accountability and appropriate intensity", and would provide funding for community-based violence intervention programs to address violent crime. In an interview with MSNBC on August 30, 2022, Moore said that he would tackle crime in Baltimore by investing in violence intervention programs like Safe Streets and We Our Us. In September 2022, Moore said he would use the "bully pulpit" of the governor's office to help recruit officers and would give the state's Fraternal Order of Police a seat at the table, telling The Washington Post, "I don't think that you can be serious about actually implementing reforms if the agencies that have to be reformed are not part of the process". In August 2025, Moore criticized Trump's decision to mobilize the National Guard in Washington, D.C. as "deeply dangerous", characterizing it as a distraction from his policies and other political problems. He also said that he would not authorize the deployment of the Maryland National Guard to police cities in Maryland and later invited Trump to walk the streets of Baltimore to see the city's public safety improvements firsthand.
=== EGFR side effects === Epidermal growth factor receptor (EGFR) inhibitors are medications used in cancer treatment. These medications commonly cause skin and nail problems, including rashes, dry skin and paronychia. Preventive intensive moisturizing with emollient ointments several times, avoidance of water-based creams and water soaks (although in certain circumstances white vinegar or potassium permanganate soaks may help), protection the skin from excessive exposure to sunshine, and soap substitutes which are less dehydrating for the skin than normal soaps, as well as shampoos that reduce the risk of scalp folliculitis, are recommended. Treatment measures with topical antibiotic medication can be helpful.
== History == Elagolix was first described in the literature in 2005. It was originally developed by the pharmaceutical company Neurocrine Biosciences, and was later developed together by Neurocrine Biosciences and AbbVie (previously Abbott Laboratories). In June 2010, Neurocrine Biosciences and Abbott announced a global agreement to develop and commercialize elagolix for the treatment of endometriosis. The medication completed phase III clinical trials for endometriosis in November 2016. Two phase III clinical trials, the Elaris Endometriosis I and II (EM-I and EM-II) studies, were conducted. The studies included almost 1,700 women, about 950 of whom were treated with elagolix. In September 2017, AbbVie filed a New Drug Application (NDA) for elagolix for the treatment of pain associated with endometriosis in the United States. The medication was approved by the FDA for the treatment of endometriosis-associated pain in the United States on 23 July 2018. It was the first new medication to be approved by the FDA for the treatment of endometriosis in more than a decade. Elagolix was the first member of a new class of GnRH modulators described as "second-generation" due to their non-peptide and small-molecule nature and oral activity to be marketed. A second member of this group, relugolix (brand name Relumina), was introduced in Japan in January 2019. In addition to endometriosis, elagolix is under development for the treatment of uterine fibroids and menorrhagia. It is in phase III clinical trials for these indications.
=== September === 1 September – Schools Minister Nick Gibb confirms that buildings at 52 schools were in immediate danger of collapse due to concrete, while 100 others have been told to close affected areas until they can have them made safe. TikTok influencer Mahek Bukhari and her mother, Ansreen Bukhari, are both sentenced to life imprisonment for the murders of Saqib Hussain and Hashim Ijazuddin. Mahek Bukhari is ordered to serve a minimum of 31 years and eight months in custody, while Ansreen Bukhari is ordered to serve at least 26 years and nine months. 3 September – Chancellor Jeremy Hunt says the UK government will "spend what it takes" to put right defective concrete in schools, but concedes that structural problems could be identified in more schools and other public buildings. Data released by the UK government indicates one in five children of school age in England are regularly missing school. 4 September – The UK government orders an urgent investigation into court buildings built in the 1990s to determine whether they contain reinforced autoclaved aerated concrete. 5 September – Birmingham City Council, the largest local authority in Europe, declares itself effectively bankrupt. The crisis, which prevents all but essential spending to protect core services, is linked to a £760m bill to settle equal pay claims, along with implementation of a new IT system. 7 September – A 10-year-old boy dies in hospital after he was electrocuted at a Blackpool hotel a few days earlier.
Sources: en.wikipedia.org
Water promotes hydrolysis and deamidation, so removing it slows degradation during transport and storage. The dry solid is also less prone to microbial growth than a solution. Reconstitution is therefore performed close to the point of use.
Reversed-phase high-performance liquid chromatography is the standard method for purity and related substances. It separates the main peak from deletion sequences and oxidation products. Mass spectrometry is frequently used alongside it to confirm molecular identity.
Aggregates, truncated sequences, and oxidation products receive the most attention. Size-exclusion chromatography covers aggregates, while reversed-phase methods resolve many chemical variants. Limits are set according to the route of administration and the expected exposure.
It is a synthetic linear peptide that acts as a dual agonist at the GIP and GLP-1 receptors. It combines a modified incretin backbone with a fatty diacid side chain that extends its circulation time. It is not a small-molecule drug and is not orally absorbed in its native form.